340binformed.org

Your Free Source for 340B News and Commentary

  • About us
  • Advertise
  • Contact
  • 340B Health

Senator Skewers Turing Exec About Disputing 340B Claims for Profit

"F these guys" one exec said to another about 340B healthcare providers 

March 17, 2016—The chairwoman of the Senate Special Committee on Aging excoriated a Turing Pharmaceuticals executive during a hearing today for instructing a subordinate to dispute 340B claims in order to boost company profits. … [Read more...]

340B Hospitals Criticize MedPAC’s Plan to Cut Their Medicare Drug Reimbursement

Commission's ideas would radically restructure drug discount program 

March 16, 2016—Safety-net hospitals are criticizing a Medicare advisory panel's recommendation that Congress should reduce Medicare payment rates for 340B hospitals’ separately payable 340B drugs by 10 percent of the average sales price (ASP), redirect the money saved to the Medicare-funded uncompensated care pool, and distribute those funds using data from the Medicare cost … [Read more...]

Delaware Bars Using 340B Drugs for Medicaid Beneficiaries

Says rule will simplify obtaining rebates and eliminate an area for provider audits 

March 15, 2016—Delaware Medicaid has adopted a rule, subject to federal Centers for Medicare & Medicaid Services approval, barring healthcare providers from using 340B-purchased drugs for managed-care and fee-for-service Medicaid beneficiaries. … [Read more...]

HHS: Price Hikes, Specialty Drugs Driving Up Drug Spending

Total spending expected to exceed half a trillion dollars in 2018 

March 10, 2016—U.S. prescription drug spending is climbing steeply and projected to keep rising as a share of total healthcare spending, the U.S. Department of Health and Human Services says in a new report. … [Read more...]

HRSA Says Drugmakers Can Give 340B Orphan Drug Discounts Voluntarily

Updates website language about October 2015 court ruling 

March 7, 2016—Although drugmakers are not required to provide rural and cancer hospitals 340B discounts on orphan drugs, they may do so voluntarily, the Health Resources and Services Administration says in an update to the Office of Pharmacy Affairs website. … [Read more...]

Trump Fleshes Out Healthcare Policies

Although drug industry "is in the private sector…[it] provide[s] a public service" 

March 3, 2016—Republican presidential candidate Donald Trump has fleshed out his healthcare agenda in a seven-point position paper that includes repealing the Affordable Care Act, giving states more control over Medicaid, and removing barriers to drug imports. … [Read more...]

Brand-name and Specialty Drug Prices Skyrocketing, AARP Study Finds

Nation might not be able to rely on lower-priced generics as a counterbalance any longer 

March 1, 2016—Retail prices for 622 brand name, generic, and specialty prescription drugs widely used by Medicare beneficiaries rose by an average of 9.4 percent in 2013, a far higher rate than in the previous seven years and far above 2013's general inflation rate of 1.5 percent, new research shows. … [Read more...]

« Previous Page
Next Page »

LATEST ARTICLES DELIVERED

Get new article alerts via email.

This field is required.

Check your inbox or spam folder now to confirm your subscription.

FOLLOW | SHARE | LIKE

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

340B Health Twitter

Twitter feed is not available at the moment.

RSS feed: 340B Employed 340B Employed

  • 340B Program Compliance Analyst Certified | UNC Health November 17, 2026
  • 340B Program Compliance Analyst Certified | UNC Health November 17, 2026
  • 340B Program Specialist | Vail Health November 17, 2026
  • Pharmacy Manager, 340B Program | Tufts Medical Center November 11, 2026
  • 340B Program Pharmacy Manager | Allies for Health + Wellbeing November 10, 2026

Copyright © 2026 · 340B Health